Pre-market · Oct 8, 9:10 am ET · After hours $2.70 -0.74%
Open$2.62
Prev close$2.70
Day range$2.50 – $2.74
Volume20.37M
Market cap$845.46M
P/E (TTM)–
Dividend yield–
PACB Stock News
Headlines matching Pacific Biosciences of California or the PACB ticker, most recent first.
CCORF Maintains Pacific Biosciences of California(PACB.US) With Buy RatingMarket news · 11 Sep 2026 · Direct mention
Piper Sandler Maintains Pacific Biosciences of California(PACB.US) With Hold Rating, Maintains Target Price $2Market news · 6 Aug 2026 · Direct mention
TD Cowen Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Maintains Target Price $3Market news · 6 Aug 2026 · Direct mention
Analysts Offer Insights on Healthcare Companies: Biodesix (BDSX), Pacific Biosciences (PACB) and Odyssey Therapeutics, Inc. (ODTX)TipRanks · 6 Aug 2026 · Direct mention
CCORF Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Maintains Target Price $3Market news · 17 Aug 2026 · Direct mention
Analysts Are Bullish on Top Healthcare Stocks: Pacific Biosciences (PACB), 20/20 Biolabs, Inc. (AIDX)PositiveTipRanks · 9 May 2026 · Direct mention
Barclays Maintains Pacific Biosciences of California(PACB.US) With Sell Rating, Cuts Target Price to $1NegativeMarket news · 14 Apr 2026 · Direct mention
Barclays Maintains Pacific Biosciences of California(PACB.US) With Hold Rating, Raises Target Price to $2PositiveMarket news · 13 Feb 2026 · Direct mention
Barclays Maintains Pacific Biosciences of California(PACB.US) With Sell Rating, Maintains Target Price $1.25Market news · 7 Oct 2026 · Direct mention
Bernstein Maintains Pacific Biosciences of California(PACB.US) With Buy Rating, Raises Target Price to $1.7PositiveMarket news · 8 Aug 2025 · Direct mention
TR | OpenAI - 4o Maintains Pacific Biosciences of California(PACB.US) With Hold Rating, Maintains Target Price $1.5Market news · 24 Aug 2025 · Direct mention
Morgan Stanley Initiates Pacific Biosciences of California(PACB.US) With Hold Rating, Announces Target Price $2Market news · 11 Aug 2025 · Direct mention
Morgan Stanley Maintains Pacific Biosciences of California(PACB.US) With Hold Rating, Maintains Target Price $2Market news · 28 May 2025 · Direct mention
Piper Sandler Maintains Pacific Biosciences of California(PACB.US) With Hold Rating, Cuts Target Price to $1.25NegativeMarket news · 16 May 2025 · Direct mention
A Quick Look at Today's Ratings for Pacific Biosciences of California(PACB.US), With a Forecast Between $2 to $3Market news · 10 May 2025 · Direct mention
Discussion
No comments yet — be the first to weigh in on PACB.
No comments yet — be the first to weigh in on PACB.